New videos include 1-1 clinician interviews and detailed product tour

Additional funds to support the company's diagnostic platform initiatives

FDA clearance is part of Company's three-part strategy to change the business paradigm for the molecular diagnostic industry

InDevR receives 510(k) market clearance for the first influenza diagnostic assay capable of distinguishing between seasonal and non-seasonal influenza A subtypes.

Industry Experts to Support Development and Commercialization

New facility offers additional space, state of the art laboratory, added manufacturing capacity

Startup introduces streamlined, robust workflow for NGS sample preparation and analysis

Flow cytometry provides a highly adaptable and quantitative method for investigating both the cellular distribution and intracellular changes that occur in tumors and peripheral lymphoid organs in response to therapy.

Session to examine how medical device and diagnostic equipment companies can use IoT to provide innovative, compliant and secure healthcare solutions

Precision Analytical, Inc., a functional medicine specialty lab, launches six (6) organic acid tests (OATs)

Live discussion with FDA and Siemens to provide an overview of the use of individualized computer simulation to predict clinical outcomes in medical device trials

Flexible, Fast, Efficient: The Expanding Role of Single-Site PMA Approval in Companion Diagnostics Development

Immunoprecipitation in combination with mass spectrometry is a powerful tool for studying disease-associated proteins

InDevR gearing up to launch FluChip-8G with AI interpretation of microarray 'big data' to enhance influenza surveillance

CytoTest announces a significant expansion of its sales team.

Cancer DNA mutations can now be detected in the blood in femtogram concentrations (one femtogram = one thousand trillionth of a gram)

The CDC's Learn the Signs Act Early team is excited about the new app launched by Childstones.org.